PMID- 31820666 OWN - NLM STAT- MEDLINE DCOM- 20210705 LR - 20210705 IS - 1541-2563 (Electronic) IS - 1541-2563 (Linking) VI - 17 IP - 1 DP - 2020 Feb TI - Acute Phase Proteins as Predictors of Survival in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease Requiring Mechanical Ventilation. PG - 22-28 LID - 10.1080/15412555.2019.1698019 [doi] AB - Few studies have tried to assess prognostic variables in chronic obstructive pulmonary disease (COPD) patients requiring mechanical ventilation (MV). We evaluated serum C reactive protein, (CRP) pre-albumin (PA) and transferrin (TR) levels in AE-COPD patients requiring MV as prognostic markers of in hospital mortality. 93 AE-COPD patients on MV were evaluated. Detailed clinical evaluation was done daily. Serum CRP & PA were measured on admission, 3rd, 8th and 16th day; TR was measured on admission, 8th and 16th day. Demographics, baseline parameters, CRP, PA and TR were correlated with mortality. Of 93 patients, 49 (52.69%) survived whereas 44 patients (47.31%) died. APACHE II, serum urea & albumin were similar in survivors & non-survivors. Baseline CRP (>/=10.5 mg/dl) had sensitivity of 60.5%, specificity of 60.2%, with area under curve (AUC) of 0.62 as predictor of mortality. CRP (>/=7 mg/dl) on day 3 had sensitivity (65.5%) and specificity (63.3%) with AUC 0.70 as predictor of mortality. Baseline serum prealbumin was 11.00 (0.09-29.26) mg/dl, and similar in survivors & non-survivors (p = 0.7). Prealbumin at day 8 (n = 50) < 13.5 mg/dl had sensitivity 54.6%, and specificity 51.4% with AUC 0.54 (95% CI 0.34-0.75) as predictor of mortality. Transferrin at day 8 (n = 50) of <148.9 had sensitivity 63.4% and specificity 61.4% with AUC 0.61 with respect to mortality. High CRP levels at baseline, persistently elevated CRP (on day 3) may predict mortality in AE-COPD patients requiring MV. Further studies are required to establish prognostic variables in this patient population. FAU - Sneh, Arora AU - Sneh A AD - Department of Pulmonary Medicine and Sleep Disorders, All India Institute of Medical Sciences, New Delhi, India. FAU - Pawan, Tiwari AU - Pawan T AUID- ORCID: 0000-0002-5136-4221 AD - Department of Pulmonary Medicine and Sleep Disorders, All India Institute of Medical Sciences, New Delhi, India. FAU - Randeep, Guleria AU - Randeep G AD - Department of Pulmonary Medicine and Sleep Disorders, All India Institute of Medical Sciences, New Delhi, India. FAU - Anant, Mohan AU - Anant M AD - Department of Pulmonary Medicine and Sleep Disorders, All India Institute of Medical Sciences, New Delhi, India. FAU - Mani, Kalaivani AU - Mani K AD - Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India. FAU - Hadda, Vijay AU - Hadda V AUID- ORCID: 0000-0001-5820-3685 AD - Department of Pulmonary Medicine and Sleep Disorders, All India Institute of Medical Sciences, New Delhi, India. FAU - Madan, Karan AU - Madan K AD - Department of Pulmonary Medicine and Sleep Disorders, All India Institute of Medical Sciences, New Delhi, India. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20191210 PL - England TA - COPD JT - COPD JID - 101211769 RN - 0 (Prealbumin) RN - 0 (Transferrin) RN - 9007-41-4 (C-Reactive Protein) SB - IM MH - Aged MH - Area Under Curve MH - C-Reactive Protein/*metabolism MH - Cigarette Smoking MH - Disease Progression MH - Female MH - Forced Expiratory Volume MH - *Hospital Mortality MH - Humans MH - Length of Stay MH - Male MH - Middle Aged MH - Prealbumin/*metabolism MH - Prognosis MH - Pulmonary Disease, Chronic Obstructive/*metabolism/mortality/physiopathology/therapy MH - *Respiration, Artificial MH - Severity of Illness Index MH - Transferrin/*metabolism OTO - NOTNLM OT - Acute phase reactants OT - COPD acute exacerbation OT - CRP OT - prognosis in AE COPD EDAT- 2019/12/11 06:00 MHDA- 2021/07/06 06:00 CRDT- 2019/12/11 06:00 PHST- 2019/12/11 06:00 [pubmed] PHST- 2021/07/06 06:00 [medline] PHST- 2019/12/11 06:00 [entrez] AID - 10.1080/15412555.2019.1698019 [doi] PST - ppublish SO - COPD. 2020 Feb;17(1):22-28. doi: 10.1080/15412555.2019.1698019. Epub 2019 Dec 10.